Regarding the end of enrollment of subjects in the Japanese clinical phase III study for patients with the new coronavirus infection, the anti-influenza virus drug “Avigan ® Tablets” FUJIFILM Toyama Chemical Co., Ltd. (Headquarters: Chuo-ku, Tokyo / President: Junji Okada, hereafter FUJIFILM Toyama Chemical) has announced the anti-influenza virus drug “Avigan ® Tablets” (generic name: […]
FUJIFILM Holdings Donates donations and medical equipment for humanitarian assistance in Ukraine FUJIFILM Holdings Co., Ltd. (Headquarters: Minato-ku, Tokyo, President and CEO: Sadaichi Goto) is worth a total of US $ 2 million (about 2.3) for humanitarian assistance to people affected by the disaster in Ukraine and its surrounding areas. We have decided to make […]
FUJIFILM Holdings Donates donations and medical equipment for humanitarian assistance in Ukraine FUJIFILM Holdings Co., Ltd. (Headquarters: Minato-ku, Tokyo, President and CEO: Sadaichi Goto) is worth a total of US $ 2 million (about 2.3) for humanitarian assistance to people affected by the disaster in Ukraine and its surrounding areas. We have decided to make […]
We have asked our hosting company to block all traffic from Russia at the IP level until further notice on FujiAddict, SonyAdddict, 43Addict, Nikonrumors, Photorumors, Leicarumors, and Pentax Rumors. We feel it is important for everyone to do their part to support the Ukrainian people and to make clear to the Russian people that the […]
Notice of firmware availability due to specification changes of our digital camera As announced on February 2, 2022 in the “Important notice for consumers processing FUJIFILM digital camera files using macOS” revised firmware for our digital cameras (GFX series and specific X series) will be released in the following schedule. 1.Models affected (1) GFX100, GFX100S, GFX […]
As a result of strong sales of new instant photo systems and digital cameras, which were launched in succession, and also the steady sales recovery of color photographic paper and broadcast and cinema lens from the impact of the COVID-19 pandemic, revenues increased by 19.0% year-over-year to ¥260.2 billion, and operating income increased 2.5 times […]
